Table 3.

Microsatellite analysis of secondary epithelial cancers





Tetranucleotides

Mononucleotides
THO-1
SEE33
D14S120
BAT26
SRY
ZP3
Patient ID
Time after HCT, y
Pathologic diagnosis
Tumor
Normal epith
Tumor
Normal epith
Tumor
Normal epith
Tumor
Normal epith
Tumor
Normal epith
Tumor
Normal epith
C3   3.5   Squamous Ca, tongue   MSI   MSI   NE   NE   MSI   NE   S   S   S   S   S   S  
B16   2   Squamous Ca, lip   MSI   S   MSI   MSI   MSI   NE   S   S   NA   NA   NE   NE  
B24
 
10
 
Squamous Ca, lip
 
MSI
 
MSI
 
MSI
 
NE
 
S
 
S
 
S
 
S
 
S
 
S
 
S
 
S
 




Tetranucleotides

Mononucleotides
THO-1
SEE33
D14S120
BAT26
SRY
ZP3
Patient ID
Time after HCT, y
Pathologic diagnosis
Tumor
Normal epith
Tumor
Normal epith
Tumor
Normal epith
Tumor
Normal epith
Tumor
Normal epith
Tumor
Normal epith
C3   3.5   Squamous Ca, tongue   MSI   MSI   NE   NE   MSI   NE   S   S   S   S   S   S  
B16   2   Squamous Ca, lip   MSI   S   MSI   MSI   MSI   NE   S   S   NA   NA   NE   NE  
B24
 
10
 
Squamous Ca, lip
 
MSI
 
MSI
 
MSI
 
NE
 
S
 
S
 
S
 
S
 
S
 
S
 
S
 
S
 

Clinical data of the patients are shown in Tables 1 and 2. Tumor indicates that laser-microdissected tumor area was analyzed; noral epith, that laser-microdissected nonmalignant epithelium adjacent to the tumor area was analyzed.

HCT indicates hematopoietic cell transplantation; Ca, cancer; MSI, microsatellite instability; NE, not evaluable; S, stable microsatellites; NA, not applicable.

or Create an Account

Close Modal
Close Modal